12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Caribou Biosciences (NASDAQ:CRBU) stock rose 50.7% to $6.15 during Thursday’s regular session. The current volume of 75.4…
Crude Oil Moves Lower; ISM Services PMI Surges In June
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Thursday.
The Dow traded down 1.38% to 33,814.23 while the NASDAQ fell 1.37% to 13,602.19. The S&P 500, also fell, dropping, 1.29% to 4,389.59.
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.
Dow Tumbles Over 300 Points; US Jobless Claims Increase More Than Projected
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.
Following the market opening Thursday, the Dow traded down 0.96% to 33,958.13 while the NASDAQ fell 1.06% to 13,645.10. The S&P 500, also fell, dropping, 0.97% to 4,403.76.
What’s Going On With ASLAN Pharmaceuticals Stock Today?
ASLAN Pharmaceuticals Ltd (NASDAQ: ASLN) released topline data from its TREK-AD Phase 2b dose-ranging study of eblasakimab in adult patients with moderate-to-severe
4 Analysts Have This to Say About ASLAN Pharma
Over the past 3 months, 4 analysts have published their opinion on ASLAN Pharma (NASDAQ:ASLN) stock. These analysts…
ASLAN Inks Licensing Deal With Zenyaku Kogyo To Commercialize Eblasakimab In Japan
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) inked a strategic licensing deal with Zenyaku Kogyo to develop and
Market-Moving News for June 22nd
ROOT: 160% | 'Car-Insurance Firm Root Gets Takeover Bid; Root Was Offered $19.34 A Share, Hasn't Managed To Negotiate A Deal' ROIV: 15% | Roivant Reports Chronic Period Data for RVT-3101 from the TUSCANY-2
Benzinga’s Top Ratings Upgrades, Downgrades For May 31, 2023
Upgrades For The Carlyle Group Inc (NASDAQ:CG), Raymond James upgraded the previous rating of Market Perform to Outperform.…
10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move.
High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.